The effect of Dexmedetomidine combined with b-ultrasound-guided nerve block in postherpes neuralgia: a prospective, randomized controlled clinical study

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900028587

Enrollment

Unknown

Registered

2019-12-28

Start date

2019-12-31

Completion date

Unknown

Last updated

2020-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Interventions

Regular treatment:Regular treatment

DEX:B-ultrasound guided nerve block +dex 1.0ug /Kg

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: A. Patients diagnosed with post-herpes zoster intercostal neuralgia without nerve block therapy; B. Aged 18-80 years; C. There was no deformity or serious infection in the spine and ribs in the nerve block area; D. Willing to accept the study and sign the study consent form.

Exclusion criteria

Exclusion criteria: A. ASA grade >=3, such as severe cardiovascular and cerebrovascular diseases combined with uncontrolled diabetes, etc.; B. patients with psychiatric and neuropathic disorders that cause paresthesia; C. Patients with a history of drug allergy; D. Patients with severe abnormal coagulation function.

Design outcomes

Primary

Measure	Time frame
Visual Analogotls Scale;threshold of pain;satisfaction;plasma concentration;blood glucose;	—

Secondary

Measure	Time frame
Infrared image;Psychological score;	—

Countries

China

Contacts

Public ContactXing Jibin

The Third Affiliated Hospital of Sun Yat-Sen University

beenjoy@qq.com+86 13512728239

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026